Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.
Jesús G MirelisLuis Escobar-LopezJuan Pablo OchoaMaría Ángeles EspinosaEduardo VillacortaMarina NavarroGuillem CasasNerea Mora-AyestaránRoberto Barriales VillaMaría Victoria Mogollón-JiménezJose Manuel Garcia-PinillaPablo Elpidio García-GranjaVicente ClimentJulian Palomino-DozaAna García-ÁlvarezMaría Álvarez-BarredoEva Cabrera-BorregoTomas Ripoll-VeraMaría Luisa Peña-PeñaElena Rodríguez-GonzálezMaría Gallego-DelgadoJosefa Gonzalez-CarrilloAna Fernández-ÁvilaJosé F Rodriguez PalomaresRamón BrugadaAntoni Bayes-GenisFernando DominguezPablo García-PavíaPublished in: European journal of heart failure (2022)
Classification of patients with DCM according to genotype and LGE improves MVA and ESHF prediction. Scar assessment with CMR and genotyping should be considered to select patients for primary prevention implantable cardioverter-defibrillator placement.